0001209191-21-067159.txt : 20211130
0001209191-21-067159.hdr.sgml : 20211130
20211130172609
ACCESSION NUMBER: 0001209191-21-067159
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211126
FILED AS OF DATE: 20211130
DATE AS OF CHANGE: 20211130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Faga Daniel
CENTRAL INDEX KEY: 0001673528
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37985
FILM NUMBER: 211460468
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANAPTYSBIO, INC
CENTRAL INDEX KEY: 0001370053
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203828755
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE, SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-362-6295
MAIL ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE, SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: ANAPTYSBIO INC
DATE OF NAME CHANGE: 20080828
FORMER COMPANY:
FORMER CONFORMED NAME: ANAPTYS BIOSCIENCES INC
DATE OF NAME CHANGE: 20060724
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-26
0
0001370053
ANAPTYSBIO, INC
ANAB
0001673528
Faga Daniel
C/O ANAPTYSBIO, INC.
10421 PACIFIC CENTER COURT, SUITE 200
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (Right to Buy)
31.12
2021-11-26
4
A
0
11000
0.00
A
2031-11-25
Common Stock
11000
11000
D
Stock Option (Right to Buy)
31.12
2021-11-26
4
A
0
2321
0.00
A
2031-11-25
Common Stock
2321
2321
D
1/36th of the total shares subject to the option shall vest on December 26, 2021 and 1/36th of the total shares subject to the option shall vest on each monthly anniversary thereafter, subject to the reporting person's continuous status as a director through each such date.
The option shall vest and become exercisable in full on February 10, 2022, subject to the reporting person's continuous status as a director through February 10, 2022.
/s/ Eric Loumeau, Attorney-in-Fact
2021-11-30